{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:34:26Z","timestamp":1768419266042,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science;","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007449","name":"Takeda Scientific Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s12185-016-2021-3","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T08:20:13Z","timestamp":1463559613000},"page":"223-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["No association between dysplasminogenemia with p.Ala620Thr mutation and atypical hemolytic uremic syndrome"],"prefix":"10.1007","volume":"104","author":[{"given":"Toshiyuki","family":"Miyata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kokame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"2021_CR1","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361:1676\u201387.","journal-title":"N Engl J Med"},{"key":"2021_CR2","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371:654\u201366.","journal-title":"N Engl J Med"},{"key":"2021_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa0810739","volume":"361","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, et al. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361:345\u201357.","journal-title":"N Engl J Med"},{"key":"2021_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/ng.2590","volume":"45","author":"M Lemaire","year":"2013","unstructured":"Lemaire M, Fremeaux-Bacchi V, Schaefer F, Choi M, Tang WH, Le Quintrec M, et al. Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet. 2013;45:531\u20136.","journal-title":"Nat Genet"},{"key":"2021_CR5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1160\/TH15-01-0007","volume":"114","author":"T Miyata","year":"2015","unstructured":"Miyata T, Uchida Y, Ohta T, Urayama K, Yoshida Y, Fujimura Y. Atypical haemolytic uraemic syndrome in a Japanese patient with DGKE genetic mutations. Thromb Haemost. 2015;114:862\u20133.","journal-title":"Thromb Haemost"},{"key":"2021_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1182\/blood-2014-06-579953","volume":"125","author":"S Bruneau","year":"2015","unstructured":"Bruneau S, Neel M, Roumenina LT, Frimat M, Laurent L, Fremeaux-Bacchi V, et al. Loss of DGK\u03b5 induces endothelial cell activation and death independently of complement activation. Blood. 2015;125:1038\u201346.","journal-title":"Blood"},{"key":"2021_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1681\/ASN.2013050453","volume":"25","author":"F Bu","year":"2014","unstructured":"Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, et al. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2014;25:55\u201364.","journal-title":"J Am Soc Nephrol"},{"key":"2021_CR8","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1111\/j.1538-7836.2007.02776.x","volume":"5","author":"V Schuster","year":"2007","unstructured":"Schuster V, Hugle B, Tefs K. Plasminogen deficiency. J Thromb Haemost. 2007;5:2315\u201322.","journal-title":"J Thromb Haemost"},{"key":"2021_CR9","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1073\/pnas.79.20.6132","volume":"79","author":"T Miyata","year":"1982","unstructured":"Miyata T, Iwanaga S, Sakata Y, Aoki N. Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site. Proc Natl Acad Sci USA. 1982;79:6132\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1073\/pnas.88.1.115","volume":"88","author":"A Ichinose","year":"1991","unstructured":"Ichinose A, Espling ES, Takamatsu J, Saito H, Shinmyozu K, Maruyama I, et al. Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. Proc Natl Acad Sci USA. 1991;88:115\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/BF00499478","volume":"22","author":"N Aoki","year":"1984","unstructured":"Aoki N, Tateno K, Sakata Y. Differences of frequency distributions of plasminogen phenotypes between Japanese and American populations: new methods for the detection of plasminogen variants. Biochem Genet. 1984;22:871\u201381.","journal-title":"Biochem Genet"},{"key":"2021_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1532\/IJH97.A20514","volume":"83","author":"T Miyata","year":"2006","unstructured":"Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol. 2006;83:217\u201323.","journal-title":"Int J Hematol"},{"key":"2021_CR13","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1055\/s-0037-1614387","volume":"82","author":"A Ooe","year":"1999","unstructured":"Ooe A, Kida M, Yamazaki T, Park SC, Hamaguchi H, Girolami A, et al. Common mutation of plasminogen detected in three Asian populations by an amplification refractory mutation system and rapid automated capillary electrophoresis. Thromb Haemost. 1999;82:1342\u20136.","journal-title":"Thromb Haemost"},{"key":"2021_CR14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1172\/JCI109034","volume":"61","author":"N Aoki","year":"1978","unstructured":"Aoki N, Moroi M, Sakata Y, Yoshida N, Matsuda M. Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J Clin Invest. 1978;61:1186\u201395.","journal-title":"J Clin Invest"},{"key":"2021_CR15","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1016\/S0021-9258(19)70806-0","volume":"255","author":"Y Sakata","year":"1980","unstructured":"Sakata Y, Aoki N. Molecular abnormality of plasminogen. J Biol Chem. 1980;255:5442\u20137.","journal-title":"J Biol Chem"},{"key":"2021_CR16","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1182\/blood-2005-09-3892","volume":"107","author":"R Kimura","year":"2006","unstructured":"Kimura R, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107:1737\u20138.","journal-title":"Blood"},{"key":"2021_CR17","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.281.5383.1662","volume":"281","author":"X Wang","year":"1998","unstructured":"Wang X, Lin X, Loy JA, Tang J, Zhang XC. Crystal structure of the catalytic domain of human plasmin complexed with streptokinase. Science. 1998;281:1662\u20135.","journal-title":"Science"},{"key":"2021_CR18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1182\/blood.V90.3.958","volume":"90","author":"V Schuster","year":"1997","unstructured":"Schuster V, Mingers AM, Seidenspinner S, Nussgens Z, Pukrop T, Kreth HW. Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. Blood. 1997;90:958\u201366.","journal-title":"Blood"},{"key":"2021_CR19","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1182\/blood-2006-04-017350","volume":"108","author":"K Tefs","year":"2006","unstructured":"Tefs K, Gueorguieva M, Klammt J, Allen CM, Aktas D, Anlar FY, et al. Molecular and clinical spectrum of type I plasminogen deficiency: a series of 50 patients. Blood. 2006;108:3021\u20136.","journal-title":"Blood"},{"key":"2021_CR20","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/bjh.12718","volume":"164","author":"M Scully","year":"2014","unstructured":"Scully M, Goodship T. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome. Br J Haematol. 2014;164:759\u201366.","journal-title":"Br J Haematol"},{"key":"2021_CR21","first-page":"27","volume":"33","author":"JM Campistol","year":"2013","unstructured":"Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa M, Grinyo JM, et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia. 2013;33:27\u201345.","journal-title":"Nefrologia"},{"key":"2021_CR22","doi-asserted-by":"publisher","first-page":"e0124655","DOI":"10.1371\/journal.pone.0124655","volume":"10","author":"Y Yoshida","year":"2015","unstructured":"Yoshida Y, Miyata T, Matsumoto M, Shirotani-Ikejima H, Uchida Y, Ohyama Y, et al. A novel quantitative hemolytic assay coupled with restriction fragment length polymorphism analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan. PLoS One. 2015;10:e0124655.","journal-title":"PLoS One"},{"key":"2021_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.molimm.2012.12.006","volume":"54","author":"X Fan","year":"2013","unstructured":"Fan X, Yoshida Y, Honda S, Matsumoto M, Sawada Y, Hattori M, et al. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome. Mol Immunol. 2013;54:238\u201346.","journal-title":"Mol Immunol"},{"key":"2021_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12185-015-1933-7","volume":"103","author":"X Fan","year":"2016","unstructured":"Fan X, Kremer Hovinga JA, Shirotani-Ikejima H, Eura Y, Hirai H, Honda H, et al. Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency. Int J Hematol. 2016;103:283\u201391.","journal-title":"Int J Hematol."},{"key":"2021_CR25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s12185-014-1655-2","volume":"100","author":"T Matsumoto","year":"2014","unstructured":"Matsumoto T, Fan X, Ishikawa E, Ito M, Amano K, Toyoda H, et al. Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p. I1157T mutation. Int J Hematol. 2014;100:437\u201342.","journal-title":"Int J Hematol"},{"key":"2021_CR26","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","volume":"185","author":"U Amara","year":"2010","unstructured":"Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, Acker B, et al. Molecular intercommunication between the complement and coagulation systems. J Immunol. 2010;185:5628\u201336.","journal-title":"J Immunol"},{"key":"2021_CR27","doi-asserted-by":"publisher","first-page":"18831","DOI":"10.1074\/jbc.M111.323287","volume":"287","author":"D Barthel","year":"2012","unstructured":"Barthel D, Schindler S, Zipfel PF. Plasminogen is a complement inhibitor. J Biol Chem. 2012;287:18831\u201342.","journal-title":"J Biol Chem"},{"key":"2021_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/jth.12837","volume":"13","author":"JH Foley","year":"2015","unstructured":"Foley JH, Peterson EA, Lei V, Wan LW, Krisinger MJ, Conway EM. Interplay between fibrinolysis and complement: plasmin cleavage of iC3b modulates immune responses. J Thromb Haemost. 2015;13:610\u20138.","journal-title":"J Thromb Haemost"},{"key":"2021_CR29","doi-asserted-by":"publisher","first-page":"e0143707","DOI":"10.1371\/journal.pone.0143707","volume":"10","author":"S Hyvarinen","year":"2015","unstructured":"Hyvarinen S, Jokiranta TS. Minor role of plasminogen in complement activation on cell surfaces. PLoS One. 2015;10:e0143707.","journal-title":"PLoS One"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-2021-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-016-2021-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-2021-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-2021-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:48:02Z","timestamp":1656118082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-016-2021-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["2021"],"URL":"https:\/\/doi.org\/10.1007\/s12185-016-2021-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]},"assertion":[{"value":"26 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}